Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

Ryota Shibaki,Shuji Murakami,Yuki Shinno,Yuji Matsumoto,Yasushi Goto,Shintaro Kanda,Hidehito Horinouchi,Yutaka Fujiwara,Noriko Motoi,Noboru Yamamoto,Yuichiro Ohe

Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

2019

Ryota Shibaki
Shuji Murakami
Yuki Shinno
Yuji Matsumoto
Yasushi Goto
Shintaro Kanda
Hidehito Horinouchi
Yutaka Fujiwara
Noriko Motoi
Noboru Yamamoto
Yuichiro Ohe

Background The aim of this study was to evaluate the usefulness of the presence of malignant pleural effusion (MPE) as a negative predictor of anti‐PD‐1 antibody efficacy.

Keywords:

Pathology
Antibody
Cell
Malignant pleural effusion
Lung cancer
Medicine
Cancer
Gastroenterology
Survival analysis
Confidence interval
Hazard ratio
Internal medicine
Nivolumab
Pembrolizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations